4SC secures EUR 41 million from successful capital increase6. July 2017|In Portfolio News|By eazee-designstudio4SC AG announced the completion of its capital increase resolved on 12 June 2017 to continue to advance its drug development programs for resminostat, 4SC-202 and 4SC-208. PrevNext
